21 Jun Notice of rescheduled AGM
Paris, France and Camberley, UK – 21 June 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual General Meeting (AGM),...
16 Jun DHSC dispute update
Paris, France and Camberley, UK – 16 June 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its ongoing dispute with...
13 Jun AGM voting
Paris, France and Camberley, UK – 13 June 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, will be holding its annual general meeting (AGM)...
01 Jun CTDA approval of PROmate® COVID-19 1 Gene and grant of CE mark for COVID-19 lateral flow self-test
Posted at 06:01h
in Uncategorized
Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the approval of its PROmate® COVID-19 1G (q16) Real-Time PCR test (for use on its Q16 instrument),...
01 Jun Publication of Annual Report and AGM voting
Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company's Annual Report and Accounts ("Annual Report") for the year ended 31 December 2021 has...